COVID-19 and thrombosis

In this webinar, our expert panel of speakers discuss and share best practice on the management of thrombosis during the COVID-19 pandemic: 
- Risk of thrombosis in COVID-19 patients
- VTE prophylaxis in COVID-19 patients
- VTE treatment in COVID-19 patients 

Speakers:

- Chair: Rani Khatib, Consultant Pharmacist Chair of UKCPA Cardiac Group
- Katherine Stirling, Consultant Pharmacist - Anticoagulation and Thrombosis
- Mary Collins, Anticoagulation Optimisation Pharmacist
    NICE have since published guidance on Reducing the risk of venous thromboembolism in over 16s with COVID-19.

    See also:

    - Critical Care #1
    - Critical Care #2 - ARDS, fluid management, renal replacement therapy (from Tuesday 31 March 2020)
    - Critical Care #3 - Vasopressors, Delirium, Routine Care in ITU (from Tuesday 14 April 2020)
      Watch now

      Related content

      Long COVID: What it is and how to manage it
      Critical Illness - Using the latest MC resource in practice
      RPS/MHRA - How to navigate medicines reclassifications